The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 19, 2016
Filed:
May. 13, 2011
Applicants:
Frederick J. Schnell, Corvallis, OR (US);
Patrick L. Iversen, Corvallis, OR (US);
Dan V. Mourich, Albany, OR (US);
Gunnar J. Hanson, Bothell, WA (US);
Inventors:
Frederick J. Schnell, Corvallis, OR (US);
Patrick L. Iversen, Corvallis, OR (US);
Dan V. Mourich, Albany, OR (US);
Gunnar J. Hanson, Bothell, WA (US);
Assignee:
Sarepta Therapeutics, Inc., Corvallis, OR (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); C12Q 1/70 (2006.01); A61K 31/713 (2006.01); C12N 15/113 (2010.01); A01K 67/027 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/713 (2013.01); A01K 67/027 (2013.01); C12N 15/1136 (2013.01); C12N 15/1138 (2013.01); G01N 33/5041 (2013.01); G01N 33/56983 (2013.01); G01N 33/6893 (2013.01); A01K 2267/03 (2013.01); C12N 2310/11 (2013.01); C12N 2310/3233 (2013.01); C12N 2310/3513 (2013.01); C12N 2320/33 (2013.01); G01N 2333/005 (2013.01); G01N 2333/54 (2013.01); G01N 2500/00 (2013.01);
Abstract
Provided are antisense oligonucleotides and other agents that target and modulate IL-17 and/or IL-23 signaling activity in a cell, compositions that comprise the same, and methods of use thereof. Also provided are animal models for identifying agents that modulate 17 and/or IL-23 signaling activity.